Nivison-Smith, Ian <br/><br/>
Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Feb 2012 
 - 302-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2011.05.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Aged<br/>Australia--epidemiology<br/>Chronic Disease<br/>Disease-Free Survival<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Middle Aged<br/>New Zealand--epidemiology<br/>Primary Myelofibrosis--mortality<br/>Registries<br/>Retrospective Studies<br/>Risk Factors<br/>Survival Rate<br/>Time Factors<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous